Targeted Drug - Palbociclib - Stops Tumour Growth in Patients With Early Breast Cancer
December 06, 2018
December 06, 2018
LONDON, England, Dec. 6 -- The Institute of Cancer Research issued the following news release:
Adding a new targeted therapy to hormone therapy halts the growth of tumour cells in women with early-stage breast cancer, new research shows.
Giving women palbociclib - already hailed as a major step forward in treating advanced breast cancer - alongside hormone therapy had a much greater effect on cell growth than the hormone treatment alone.
Palbociclib alongsi . . .
Adding a new targeted therapy to hormone therapy halts the growth of tumour cells in women with early-stage breast cancer, new research shows.
Giving women palbociclib - already hailed as a major step forward in treating advanced breast cancer - alongside hormone therapy had a much greater effect on cell growth than the hormone treatment alone.
Palbociclib alongsi . . .